Cargando…

Histone Acetylation and Modifiers in Renal Fibrosis

Histones are the most abundant proteins bound to DNA in eukaryotic cells and frequently subjected to post-modifications such as acetylation, methylation, phosphorylation and ubiquitination. Many studies have shown that histone modifications, especially histone acetylation, play an important role in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Fengchen, Zhuang, Shougang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086452/
https://www.ncbi.nlm.nih.gov/pubmed/35559244
http://dx.doi.org/10.3389/fphar.2022.760308
_version_ 1784704003974627328
author Shen, Fengchen
Zhuang, Shougang
author_facet Shen, Fengchen
Zhuang, Shougang
author_sort Shen, Fengchen
collection PubMed
description Histones are the most abundant proteins bound to DNA in eukaryotic cells and frequently subjected to post-modifications such as acetylation, methylation, phosphorylation and ubiquitination. Many studies have shown that histone modifications, especially histone acetylation, play an important role in the development and progression of renal fibrosis. Histone acetylation is regulated by three families of proteins, including histone acetyltransferases (HATs), histone deacetylases (HDACs) and bromodomain and extraterminal (BET) proteins. These acetylation modifiers are involved in a variety of pathophysiological processes leading to the development of renal fibrosis, including partial epithelial-mesenchymal transition, renal fibroblast activation, inflammatory response, and the expression of pro-fibrosis factors. In this review, we summarize the role and regulatory mechanisms of HATs, HDACs and BET proteins in renal fibrosis and provide evidence for targeting these modifiers to treat various chronic fibrotic kidney diseases in animal models.
format Online
Article
Text
id pubmed-9086452
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90864522022-05-11 Histone Acetylation and Modifiers in Renal Fibrosis Shen, Fengchen Zhuang, Shougang Front Pharmacol Pharmacology Histones are the most abundant proteins bound to DNA in eukaryotic cells and frequently subjected to post-modifications such as acetylation, methylation, phosphorylation and ubiquitination. Many studies have shown that histone modifications, especially histone acetylation, play an important role in the development and progression of renal fibrosis. Histone acetylation is regulated by three families of proteins, including histone acetyltransferases (HATs), histone deacetylases (HDACs) and bromodomain and extraterminal (BET) proteins. These acetylation modifiers are involved in a variety of pathophysiological processes leading to the development of renal fibrosis, including partial epithelial-mesenchymal transition, renal fibroblast activation, inflammatory response, and the expression of pro-fibrosis factors. In this review, we summarize the role and regulatory mechanisms of HATs, HDACs and BET proteins in renal fibrosis and provide evidence for targeting these modifiers to treat various chronic fibrotic kidney diseases in animal models. Frontiers Media S.A. 2022-04-26 /pmc/articles/PMC9086452/ /pubmed/35559244 http://dx.doi.org/10.3389/fphar.2022.760308 Text en Copyright © 2022 Shen and Zhuang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Shen, Fengchen
Zhuang, Shougang
Histone Acetylation and Modifiers in Renal Fibrosis
title Histone Acetylation and Modifiers in Renal Fibrosis
title_full Histone Acetylation and Modifiers in Renal Fibrosis
title_fullStr Histone Acetylation and Modifiers in Renal Fibrosis
title_full_unstemmed Histone Acetylation and Modifiers in Renal Fibrosis
title_short Histone Acetylation and Modifiers in Renal Fibrosis
title_sort histone acetylation and modifiers in renal fibrosis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086452/
https://www.ncbi.nlm.nih.gov/pubmed/35559244
http://dx.doi.org/10.3389/fphar.2022.760308
work_keys_str_mv AT shenfengchen histoneacetylationandmodifiersinrenalfibrosis
AT zhuangshougang histoneacetylationandmodifiersinrenalfibrosis